LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
-
Published:2022-05
Issue:7
Volume:39
Page:110812
-
ISSN:2211-1247
-
Container-title:Cell Reports
-
language:en
-
Short-container-title:Cell Reports
Author:
Westendorf KathrynORCID, Žentelis Stefanie, Wang Lingshu, Foster Denisa, Vaillancourt Peter, Wiggin Matthew, Lovett Erica, van der Lee RobinORCID, Hendle Jörg, Pustilnik Anna, Sauder J. MichaelORCID, Kraft Lucas, Hwang Yuri, Siegel Robert W.ORCID, Chen Jinbiao, Heinz Beverly A., Higgs Richard E., Kallewaard Nicole L., Jepson KevinORCID, Goya Rodrigo, Smith Maia A.ORCID, Collins David W., Pellacani Davide, Xiang Ping, de Puyraimond Valentine, Ricicova Marketa, Devorkin Lindsay, Pritchard CaitlinORCID, O’Neill Aoise, Dalal Kush, Panwar Pankaj, Dhupar Harveer, Garces Fabian A.ORCID, Cohen Courtney A., Dye John M., Huie Kathleen E., Badger Catherine V., Kobasa DarwynORCID, Audet JonathanORCID, Freitas Joshua J., Hassanali Saleema, Hughes Ina, Munoz Luis, Palma Holly C., Ramamurthy Bharathi, Cross Robert W., Geisbert Thomas W., Menachery Vineet, Lokugamage Kumari, Borisevich Viktoriya, Lanz IlianaORCID, Anderson Lisa, Sipahimalani Payal, Corbett Kizzmekia S., Yang Eun Sung, Zhang Yi, Shi Wei, Zhou Tongqing, Choe Misook, Misasi John, Kwong Peter D., Sullivan Nancy J., Graham Barney S.ORCID, Fernandez Tara L., Hansen Carl L., Falconer EsterORCID, Mascola John R.ORCID, Jones Bryan E.ORCID, Barnhart Bryan C.
Subject
General Biochemistry, Genetics and Molecular Biology
Reference70 articles.
1. Immunity to SARS-CoV-2 variants of concern;Altmann;Science,2021 2. Extremely potent human monoclonal antibodies from COVID-1 9 convalescent patients;Andreano;Cell,2021 3. Five reasons why COVID herd immunity is probably impossible;Aschwanden;Nature,2021 4. COVID-19 Long-Acting AntiBody (LAAB) Combination AZD7442 Rapidly Advances into Phase III Clinical Trials;AstraZeneca,2020 5. Emergence of a highly fit SARS-CoV-2 variant;Baric;N. Engl. J. Med.,2020
Cited by
286 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|